by MEGIN | Feb 28, 2022 | MEGIN News
HELSINKI, FINLAND (March 07, 2022) – MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, by the University of Nebraska Medical Center (UNMC). UNMC scientists and clinicians are at the...
by MEGIN | Feb 18, 2022 | MEGIN News
It’s a first in Switzerland: the Human Neuroscience Platform (HNP) now hosts a magnetoencephalography (MEG) facility with the purchase of a MEGIN TRIUX™ neo, a state-of-the-art scanner that allows non-invasive analysis of brain activity. This acquisition is the result...
by MEGIN | Jan 27, 2022 | MEGIN News
MEGIN is pleased to announce the sale of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, to the Norman Fixel Institute for Neurological Diseases at University of Florida Health (UF Health). The Norman Fixel Institute coordinates the...
by MEGIN | Jan 18, 2022 | MEGIN News
MEGIN is delighted to be joining the Association of British HealthTech Industries (ABHI) UK Pavilion at Arab Health 2022, which is taking place from 24- 27 January in Dubai. The exhibition – the largest event of its kind in the Middle East – will showcase more than...
by MEGIN | Dec 12, 2021 | MEGIN News
Despite its success in pre-surgical evaluation in localising brain activity, as well as being approved for the pre-surgical evaluation of medically refractory epilepsy, Magnetoencephalography (MEG) is often overlooked by physicians during the referral stage. Although...
by MEGIN | Jun 1, 2021 | MEGIN News
HELSINKI, FINLAND (June 1, 2021) – MEGIN is pleased to announce the acquisition of a TRIUX™ neo by The Centre For Cognitive Neuroimaging (CCNi), at the Institute for Neuroscience and Psychology at the University of Glasgow. This research facility will continue its...
